Loading clinical trials...
Loading clinical trials...
Remote Assessment of Outpatient With SARS-CoV-2
Outpatient management of patients with a milder form of COVID may be associated to an unfavorable initial or deferred course in relation to the pathology.. Outpatients represent the bulk of patients with COVID-19. To know their evolution, their secondary complications and identifying a profile of "at risk" patients is essential for the prevention and care of future non-hospitalized patients, in an epidemic context still active. This study could make it possible to redefine the follow-up of outpatients. The study consists of a simple questionnaire and possibly a teleconsultation.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Médecine Interne A
Limoges, France
Start Date
February 1, 2022
Primary Completion Date
December 12, 2022
Completion Date
June 12, 2023
Last Updated
May 4, 2022
400
ESTIMATED participants
Questionnaire
OTHER
Lead Sponsor
University Hospital, Limoges
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04896866